GPX Embolic clinical procedures for tumors and other oncology uses.

GPX™ Early Clinical Results

Clinical cases with the GPX Embolic Device from a multi-center clinical trial

Tumor Devascularization

Right renal tumor successfully embolized with GPX resulting in complete occlusion of the target vessels and resolution of chronic hematuria

Before GPX tumor embolization

Baseline angiogram

During GPX embolization of tumor

Angiogram post-GPX delivery through microcatheter

After GPX embolic delivery and complete occlusion

DSA post-GPX delivery

Portal Vein Embolization

Portal vein segment successfully embolized with GPX resulting in a complete cast of a venous system terminal vessel bed and effective occlusion throughout follow-up

Portal vein before GPX embolization

Baseline angiogram

GPX used for venous embolization

Angiogram post-GPX delivery through microcatheter

After GPX embolic delivery

DSA post-GPX delivery

Interventional Oncology Use

Renal angiomyolipoma embolization completed using interventional oncology techniques resulting in complete occlusion of the target vessels

Renal tumor before Fluidx GPX

Baseline angiogram

GPX devascularizes tumor with no DMSO

DSA post-GPX delivery

‡ Early clinical case studies. Data on file. Fluidx Medical Technology.

The GPX Embolic Device is under development and does not have marketing clearance or approval in any market at this time.  For investigational use (in New Zealand) only.